Recombinant Escherichia coli Multidrug efflux pump subunit AcrB (acrB), partial

Code CSB-YP335613ENV
MSDS
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP335613ENV-B
MSDS
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP335613ENV
MSDS
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP335613ENV
MSDS
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
acrB
Uniprot No.
Alternative Names
acrB; acrE; b0462; JW0451; Multidrug efflux pump subunit AcrB; AcrAB-TolC multidrug efflux pump subunit AcrB; Acridine resistance protein B
Species
Escherichia coli (strain K12)
Protein Length
Partial
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
AcrA-AcrB-AcrZ-TolC is a drug efflux protein complex with broad substrate specificity that uses the proton motive force to export substrates.; (Microbial infection) Involved in contact-dependent growth inhibition (CDI), acts downstream of BamA, the receptor for CDI. Its role in CDI is independent of the AcrA-AcrB-TolC efflux pump complex.
Gene References into Functions
  1. It has been demonstrated that an intact AcrAB-TolC efflux pump is crucial to the development of bacterial quinolone resistance. Its activity is complemented by expression of the alternative AcrEF efflux pump. PMID: 28520511
  2. Data show that the conformational changes occurring in multidrug resistance-associated protein AcrB enable the formation of a layer of structured waters on the internal surface of the transport channel. PMID: 29339082
  3. the gate loop mutations effects on AcrB solution energetics (fold, stability, molecular dynamics) and on the in vivo efflux of Erythromycin and Doxorubicin. Finally, we discuss the efflux and the discrepancy between the structural and the functional experiments for Erythromycin in these gate loop mutants. PMID: 29126836
  4. The T37W/A100W double mutant AcrB exports ethidium bromide (EtBr) more actively than wild-type AcrB. PMID: 29317622
  5. Energy-coupling mechanism of the multidrug resistance transporter AcrB: Evidence for membrane potential-driving hypothesis through mutagenic analysis. PMID: 28497315
  6. Ten phosphorus ylides were compared in multidrug efflux pump system consisting of the subunits acridine-resistance proteins A and B (AcrA and AcrB) and the multidrug efflux pump outer membrane factor TolC (TolC) and in AcrAB-TolC-deletion. PMID: 27815466
  7. Data show that CsrA binds directly to the 5' end of the transcript encoding AcrAB. PMID: 29040729
  8. It has been found that both AcrA and AcrB lasted for approximately 6 days in live E. coli cells, and the stability of AcrB depended on the presence of AcrA but not on active antibiotic efflux. PMID: 27549795
  9. Two phenylalanine residues located adjacent to the substitution sensitive glycine residues of acrB play a role in blocking the pathway upon rigidification of the loop, since the removal of the phenyl rings from the rigid loop restores drug transport activity PMID: 28987732
  10. Our data show for the first time effects of various substrate-binding pocket mutations on the kinetics of efflux of two substrates by the AcrB pump. They also confirm interactions between substrates and drugs predicted by MD simulation studies, and also reveal areas that need future research. PMID: 27789287
  11. Dihydroartemisinine 27 (DHA27) reduced multidrug resistance-associated protein acrB's mRNA expression in a dose-dependent manner. PMID: 27869748
  12. AcrBA-TolC complex becomes unstable upon the induction of AcrD, which presumably replaces AcrB in the ternary complex. Such instability is suppressed upon the addition of AcrB-specific substrates. The assembly of resistance-nodulation-cell division-type efflux system is a regulated dynamic process that provides bacteria with a highly flexible repertoire of survival strategies to cope with a wide spectrum of antibiotics. PMID: 26916090
  13. TolC-AcrB interaction only stable on the simulated time scale when both proteins engage in a tip to tip manner. PMID: 27045078
  14. multiple deletion of acrB, acrD, and mdtABC resulted in a significant decrease in enterobactin export and that plasmids carrying the acrAB, acrD, or mdtABC genes restored the decrease in enterobactin export exhibited by the DeltaacrB acrD mdtABC mutant. PMID: 25259870
  15. Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter. PMID: 24914123
  16. Results suggested that the unfolding of the trimeric AcrB started with a local structural rearrangement. PMID: 24715637
  17. AcrAB-TolC pump effluxes regulate cellular metabolites that are toxic and have a signaling role. PMID: 24043404
  18. Genetic defects in SoxS, MarA, or AcrB underlie superoxide-mediated protection of Escherichia coli from antimicrobials. PMID: 23979754
  19. In addition to the missense mutations in these strains, we detected 7, 20, and 15 nonsense mutations in acrA, acrB, and tolC, respectively. PMID: 24065639
  20. Data indicate that not all conserved residues are important for AcrB function and not all critical residues are conserved. PMID: 22877148
  21. analysis of porter domain opening and closing motions in the multi-drug efflux transporter AcrB PMID: 23088914
  22. used molecular dynamics simulation to examine the binding of nine substrates, two inhibitors, and two nonsubstrates to the distal binding pocket of AcrB, identified earlier by X-ray crystallography PMID: 23175790
  23. Data show that AcrZ (formerly named YbhT) associates with the AcrAB-TolC complex. PMID: 23010927
  24. insight from mutagenesis studies on AcrB trimer stability and efflux activity PMID: 22163011
  25. Four amino acid residues in the vestibule of AcrB play roles role in substrate transport. PMID: 21856849
  26. The structural characterization results suggest that the oligomerization of AcrB occurs through a three-stage pathway involving folded monomers. PMID: 21664361
  27. fluoroquinolone resistance appeared to be a stepwise phenomenon, with MIC increasing as point mutations in gyrA increased, but high-level- and multidrug resistance associated with fluoroquinolone resistance reflected overexpression of AcrAB efflux pump PMID: 21194332
  28. Substrate enters AcrB from the lower part of the cleft before binding to the binding pocket PMID: 20804453
  29. Performed extensive targeted molecular dynamics simulations mimicking the functional rotation of AcrB containing doxorubicin. PMID: 20548943
  30. ligands bind not only to the wall of central cavity but also to a new periplasmic site within the deep external depression formed by the C-terminal periplasmic loop PMID: 16166543
  31. The observed pulsating behavior in inducible transcription of acrB is a systems property arising from the dependence of gene expression on multidrug resistance determinants. PMID: 16461398
  32. crystal structures of AcrB with and without substrates PMID: 16915237
  33. crystallographic structure of trimeric AcrB determined at 2.9 and 3.0 angstrom resolution; structural data imply an alternating access mechanism and a novel peristaltic mode of drug transport by this type of transporter PMID: 16946072
  34. Thr978 functions through hydrogen bonding with Asp407 and protonation of the latter alters the salt bridging and hydrogen bonding pattern in the proton relay network, thus initiating a series of conformational changes that result in drug extrusion. PMID: 17015667
  35. x-ray structures of four AcrB mutants, the D407A, D408A, K940A, and T978A mutants, in which the structure of this tight electrostatic network is expected to become disrupted; these mutant proteins revealed remarkably similar conformations PMID: 17015668
  36. The crystal structure of trimeric AcrB in complex with a designed ankyrin-repeat protein inhibitor suggests a transport pathway not through the central pore but through the identified channels in the individual AcrB subunits. PMID: 17194213
  37. analysis of the TolC/AcrAB complex from E. coli PMID: 17360572
  38. AcrB forms a mixture of quaternary structures (from monomer to heavy oligomer) in detergent solution. PMID: 17467658
  39. This study showed that conformational changes, including the closure of the external cleft in the periplasmic domain, are required for drug transport by AcrB. PMID: 17905989
  40. Measurement of the affinity of ligands to AcrB protein. PMID: 17910961
  41. The results suggest that AcrA, AcrB and TolC components of multidrug efflux pumps do not associate in an "all-or-nothing" fashion but accommodate a certain degree of flexibility. PMID: 18024521
  42. The results support the presence of the asymmetric AcrB trimer in E. coli membranes and the functional rotation mechanism. PMID: 18223659
  43. AcrS represses the gene expression of multidrug efflux genes, acrA and acrB. PMID: 18567659
  44. Phenylalanine point mutations in the hydrophobic binding pocket in AcrB alters drug susceptibility. PMID: 18849422
  45. structure of AcrB in complex with deoxycholate at 3.85 A resolution; evidence suggests that bile acid is transported out of the cell via the periplasmic vestibule of the AcrAB-TolC complex PMID: 19023693
  46. intact cells of E coli containing the intact multiprotein complex AcrB-AcrA-TolC are used to measure the kinetic constants for various cephalosporins PMID: 19307562
  47. Study conclude that the C-terminal domain of AcrA plays an important role in the assembly and function of AcrAB-TolC efflux pump. PMID: 19411330
  48. Membrane-located carboxylates play a substantial role as a central element of the proton translocation pathway in AcrB and other members of the resistance nodulation and cell division superfamily. PMID: 19425588
  49. AcrB trimer shows different conformations of each monomer showing a potential rotational peristaltic pump mechanism for transport PMID: 16946072

Show More

Hide All

Subcellular Location
Cell inner membrane; Multi-pass membrane protein.
Protein Families
Resistance-nodulation-cell division (RND) (TC 2.A.6) family
Database Links
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1